Liquid interferon-β formulations

Details Liquid interferon-β formulations Liquid interferon-β formulations

2005-08-02

2005-08-02

Andres, Janet (Department: 1646)

Drug, bio-affecting and body treating compositions

Lymphokine

Interferon

C514S002600, C514S004300, C514S008100, C530S351000

Reexamination Certificate

active

06923956

ABSTRACT:
The present invention relates to liquid formulations of human interferon-β. The formulations are characterized in that they have a buffer with a pH in the weakly acidic to neutral range of between 5 and 8, preferably between over 5.5 and 8, and that they exhibit high stability of the interferon-β in solution while retaining the molecular integrity.

REFERENCES:
patent: 5151265 (1992-09-01), Hwang-Felgner et al.
patent: 5358708 (1994-10-01), Patel
patent: 0 284 249 (1988-09-01), None
patent: 0 374 257 (1990-06-01), None
patent: 0 529 300 (1993-03-01), None
patent: WO89/02750 (1989-04-01), None
patent: WO92/15614 (1992-09-01), None
patent: 98 28007 (1998-07-01), None
Abstract/Figure, EMBL Research Reports, Table of Contents (1 page) 2001.
“Opposition of Bioceuticals Arzneimittel AG” to EP APN 98950074.9: Jul. 4, 2003; Jul. 31, 2003.
“Opposition of Intellectual Property Services” to EP APN 98950074.9: Jul. 4, 2003; Jul. 10, 2003.

Affiliated with

Also associated with

Rating

Liquid interferon-β formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Liquid interferon-β formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liquid interferon-β formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3503970